Inflammatory immune reactions occur during transplant rejections and a
utoimmune diseases. Such reactions are mediated by cytokines, includin
g interleukin-8 (IL-8). Cyclosporin A (CsA) exerts immunosuppressive a
ctivities1,2 by binding to immunoregulatory proteins termed cyclophili
ns3. The anti-inflammatory effects of CsA are still not fully understo
od. Searching for novel neutrophil-activating proteins, we observed th
at an antiserum against human recombinant Interleukin-8 (IL-8) cross-r
eacted with cyclophilins in Western blots. Furthermore, native IL-8 wa
s found to specifically bind CsA, whereas biologically inactive analog
s of CsA were not bound by IL-8. Putative binding sites for CsA on IL-
8 could be identified on the basis of structural similarities between
IL-8 and cyclophilin. However, IL-8 lacks peptidyl-prolyl-isomerase (P
Plase) enzyme activity, which is regarded as a characteristic of cyclo
philins4,5,6. We conclude that the specific binding of CsA to IL-8 may
explain some of the anti-inflammatory effects of CsA. IL-8 may be a n
ovel member of the cyclophilins lacking PPlase activity.